FGF19 and morbid obesity: Although increased FGF 19 levels have been observed in patients with morbid obesity but without DM at 12 months after sleeve gastrectomy (SG) [14], information regarding bile acids, FGF 19 and NAFLD dynamics in patients with T2DM after bariatric surgery is essential, but remains completely lacking.